International reference pricing is a form of government price setting in which U.S. bureaucrats could determine the value of our medicines based on how foreign governments and politicians value these treatments and cures. Not only does international reference pricing allow foreign politicians to decide what your medicines are worth and what diseases are worth investing in, but it lets policies set by foreign politicians influence how our government makes decisions for American patients.